Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.

Up to 75% of people with serious mental illness (SMI) such as schizophrenia and bipolar disorder have co-occurring substance use disorders (dual diagnosis). Dual diagnosis can have an adverse effect on treatment and prognosis of SMI. To evaluate the effects of risperidone compared to treatment with other antipsychotics (first-generation and other second-generation antipsychotics) used in people with serious mental illness and co-occurring substance misuse.

http://cash.libraryservices.nhs.uk/database/?entryid20=67286

Source: Current Awareness Service for Health (CASH) - May 25, 2018 Category: Consumer Health News Source Type: news